Dr. Priyanka Banerjee earned her Ph.D. in Biochemistry (Molecular Biology) from India. She has more than 15 years of experience in Molecular Biology, Cancer biology, and is currently working working on metastatic cancer progression, cellular crosstalk in tumor microenvironment in her role as postdoctoral research associate at Texas A&M University.
Dr. Banerjee has extensive experience reviewing for multiple journals (more than 12 journals), and has published her own work in peer reviewed journals, including, Cancer Immunology Research, Redox Biology, Scientific Reports, Journal of Clinical Microbiology, Clinical Microbiology and Infection etc.
Dr. Dawn Elizabeth Bowles, PhD is Assistant Professor in Surgery within the Division of Surgical Sciences at Duke University School of Medicine. She obtained her Ph.D. in Microbiology from Louisiana State University.
Dr. Andreas Brodehl is a Principal Investigator at the Heart and Diabetes Center NRW, University Hospital of the Ruhr-University Bochum, Erich and Hanna Klessmann Institute.
His research interests include genetic cardiomyopathies, using different models such as cardiomyocytes derived from induced pluripotent stem cells, and mouse and zebrafish for functional and structural analysis. In addition, he uses explanted myocardial tissue for histology, gene expression and structural investigations.
I am a full-time academic professor with a specificity in neuromuscular and cardiovascular physiology in the Department of Exercise and Health Sciences at University of Taipei. I completed a M.Sc. degree in Sports Sciences from Brunel University, the UK, in 2007 and a Ph.D. degree in the School of Health and Human Sciences, Southern Cross University, Australia in 2011. My current research interests focus on the effects of training load monitoring, exercise recovery intervention on autonomic nervous function, effects of biofeedback training on cardiovascular adaptation, and effects of ageing on neuromuscular function, physical activity and health, and football/futsal sciences
Davide Chicco is a scientific researcher at the University of Toronto. He received his PhD. from Politecnico di Milano in 2014, and his MSc. in Computer Science from the University of Genoa, Italy in 2010. From September 2018 to January 2020 he was a researcher at the University Health Network (Toronto, Ontario, Canada). Davide Chicco's research centres on biomedical informatics and machine learning.
Dr. Anissa Daliry is a biologist at the Federal College of Pernambuco (UFPE) and holds a master's degree and a PhD in cellular and molecular biology from FIOCRUZ and a postdoctoral degree from Biophysics/UFRJ. Dr. Anissa is a permanent professor of Cell and Molecular Biology program, IOC/FIOCRUZ (level 7/ CAPES) and young scientist of our state/FAPERJ (2021-2024). Her main research focus is to study molecular, physiological pathways and mechanisms involved in the development of cardiovascular and metabolic diseases such as obesity, metabolic syndrome, diabetes, hypertension, non-alcoholic fatty liver disease (NAFLD) and Chagas disease. She performs pre-clinical and clinical studies. She coordinates the postgraduate course "Cardiovascular and Metabolic Diseases: from bench to the bedside." She is a reviewer for 13 indexed international journals. Since 2020, she has collaborated in the Longitudinal Study of Brazilian Health, ELSA-BRASIL. She is also a member of the Liver Center and the Brazilian Society of Pharmacology and Experimental Therapeutics (SBFte). She develops projects in technological innovation with the development of a medical device for the quantification of hepatic steatosis. Dr. Anissa is a member of the research directory group entitled: Longitudinal Study of Adult Health - RJ/Fiocruz Research Center, coordinated by Dr. Rosane Griep/IOC and leader of the CNPq research group entitled: Study group on pathophysiology and therapy of chronic non-communicable and infectious diseases.
Dr. Dong Peixin is currently working on the roles of genetic and epigenetic mechanisms (especially non-coding RNA networks) underlying cancer stem cells, EMT, chemoresistance and cancer metastasis in Obstetrics and Gynecology, Hokkaido University, Japan. Dr. Dong has published more than 70 papers in international journals. Dr. Dong has been serving as Associate Editors of Frontiers in Pharmacology, Frontiers in Oncology, BMC Cancer, All Life, Journal of Cellular and Molecular Medicine, European Journal of Medical Research, Current Gene Therapy, and Editorial Board members of PeerJ, Clinical & Experimental Metastasis, PLOS ONE, Genes, Biomolecules, Bioengineered, Chinese Clinical Oncology, and Gynecology and Pelvic Medicine. Dr. Dong is the recipient of multiple awards.
Prf. Chengming Fan is a Surgeon in the Department of Cardiovascular Surgery at Central South University. HIs current basic research interests include treatment of ischemic heart disease with human induced pluripotent stem cells (hiPSC)-related strategy and with preclinical animal models.
Research Fellow and Clinical Nurse, Centre for Heart Rhythm Disorders, University of Adelaide. Specialising in novel models of care delivery and lifestyle and cardiovascular risk factor management to improve outcomes in cardiovascular disease.
Dr. Praveen Kumar Korla is a highly accomplished bioinformatics Scientist who has made significant contributions to the fields of bioinformatics, cancer genomics, and molecular biology. He obtained his Ph.D. in Bioinformatics from Asia University, Taiwan, in 2015, following an MSc in Bioinformatics and a BSc in Biotechnology from Sri Venkateswara University, Tirupati, India. With a solid educational background, Dr. Korla has excelled in his career and held esteemed positions at renowned institutions. Currently serving as a Bioinformatician at North Carolina State University (NCSU). Dr. Korla utilizes his extensive knowledge and expertise in bioinformatics, cancer genomics, and molecular biology to contribute to cutting-edge research projects. Dr. Korla's impact in the field is evident through his extensive research publications, covering diverse topics ranging from somatic mutational landscapes in melanoma development to functional and regulatory elements of cancer-associated fusion events. His dedication, expertise, and contributions continue to advance scientific understanding in bioinformatics and related fields.
1997: PhD Cancer Research Centre of the Russian Academy of Medical Sciences, Moscow.
1997-2001: Postdoc at the University of Regensburg
2001-2007: Junior group leader/PI and lecturer, University of Heidelberg.
2007- 2010:Senior group leader/PI and senior lecturer, University of Heidelberg
2010-2013: Professor, head of the Lab for Cellular and Molecular Biology of Innate Immunity;
2013-permanent: Professor, head of Department for Innate Immunity and Tolerance, University of Heidelberg.
Dr. Andreas Leiherer is Co-Chair of Basic and Molecular Research, and Associate Professor within the Molecular Biology Laboratory at the Vorarlberg Institute for Vascular Investigation (VIVIT) , Austria.
His research interests include Molecular Biology, Diabetes, Atherosclerosis, Insulin Resistance, HIV, Metabolism, Infection, Metabolic Diseases, and Nutrition.